does bpc-157 show up on a drug test The Peptide Gold Rush Is Coming BPC-157 - Wikipedia

For BPC-157, one PubMed study reported an LoD of approximately 15 ng/mL in plasma using specialized LC-MS methods

Figure 1: Changes in body weight from baseline to the end of treatment at week 26 associated with the trial product estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo

In comparison to treatment with 3.0 mg of liraglutide, the treatment group administered a 4.5 mg dose of cagrilintide experienced a greater reduction in weight loss by 1.8%

Under current regulations a number of widely used unapproved peptides are banned for use by compounding pharmacies in the United States

Nothing here is medical advice or a dosing recommendation

Anyone interested in the regulatory outcome should monitor the FDA's formal rulemaking process, which must follow the advisory committee recommendation before any change takes legal effect